Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

1.9K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.9K
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

833
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
833
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

1.0K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.0K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

1.2K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.2K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

976
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
976

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diagnostic criteria for invasive pulmonary aspergillosis in COPD patients.

American journal of respiratory and critical care medicine·2026
Same author

How artificial intelligence could improve the diagnosis and management of COPD: a perspective from GOLD.

American journal of respiratory and critical care medicine·2026
Same author

Distal Airway Inflammation Is Linked to Small Airway Dysfunction in Asthma.

Medical sciences (Basel, Switzerland)·2026
Same author

Global disparities in chronic dyspnoea prevalence in population-based studies: a comprehensive literature review.

European respiratory review : an official journal of the European Respiratory Society·2026
Same author

Functional dyspnea as an early marker of vulnerability to persistent physical symptoms in the CONSTANCES population-based cohort.

Journal of psychosomatic research·2026
Same author

Short-term prediction of COPD exacerbations based on wearable vital sign monitoring.

PLOS digital health·2026

Related Experiment Video

Updated: Feb 12, 2026

Author Spotlight: Efficacy of Auricular Pressure Bean Therapy in Reducing Wheezing Symptoms
02:34

Author Spotlight: Efficacy of Auricular Pressure Bean Therapy in Reducing Wheezing Symptoms

Published on: May 10, 2024

1.9K

Stable COPD Treatment: Where are We?

Nicolas Roche1

  • 1a Respiratory and Intensive Care Medicine, Hôpital Cochin (AP-HP) , University Paris Descartes (EA2511) , Paris , France.

COPD
|April 3, 2018
PubMed
Summary
This summary is machine-generated.

New pharmacological treatments for Chronic Obstructive Pulmonary Disease (COPD) offer limited benefits due to fixed lung damage. Clinical relevance and individual risks complicate treatment selection, necessitating adherence to evidence-based guidelines.

Keywords:
BronchodilatorsCOPDCorticosteroidsTreatment

More Related Videos

Author Spotlight: Enhancing Flavor Interaction of Food Using Matcha Microcapsules
05:22

Author Spotlight: Enhancing Flavor Interaction of Food Using Matcha Microcapsules

Published on: July 26, 2024

1.4K
Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
07:10

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease

Published on: August 24, 2019

10.5K

Related Experiment Videos

Last Updated: Feb 12, 2026

Author Spotlight: Efficacy of Auricular Pressure Bean Therapy in Reducing Wheezing Symptoms
02:34

Author Spotlight: Efficacy of Auricular Pressure Bean Therapy in Reducing Wheezing Symptoms

Published on: May 10, 2024

1.9K
Author Spotlight: Enhancing Flavor Interaction of Food Using Matcha Microcapsules
05:22

Author Spotlight: Enhancing Flavor Interaction of Food Using Matcha Microcapsules

Published on: July 26, 2024

1.4K
Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
07:10

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease

Published on: August 24, 2019

10.5K

Area of Science:

  • Pulmonology
  • Pharmacology
  • Clinical Medicine

Background:

  • The therapeutic landscape for Chronic Obstructive Pulmonary Disease (COPD) has expanded with new pharmacological agents, combinations, and devices.
  • Selecting optimal COPD treatments is challenging due to fixed lung damage and limited head-to-head comparisons between options.

Purpose of the Study:

  • To discuss the complexities in hierarchizing pharmacological COPD treatments.
  • To highlight the importance of defining clinically relevant changes and individualizing treatment risk-benefit assessments.

Main Methods:

  • Review of current pharmacological treatments for COPD.
  • Analysis of challenges in evidence interpretation and guideline development.
  • Discussion on the role of future biomarkers in personalized medicine.

Main Results:

  • Current COPD treatment options offer limited improvements due to irreversible lung damage.
  • Guidelines involve subjective interpretation of evidence, making clinical relevance determination complex.
  • Individualized risk-benefit analysis is crucial but difficult without comparative data.

Conclusions:

  • Prescribing pharmacological COPD treatments requires careful consideration of established indications from high-level studies and guidelines.
  • Future advancements in systems biology and medicine may provide biomarkers to aid in personalized treatment selection.
  • Adherence to evidence-based guidelines remains paramount for appropriate COPD management in the absence of definitive comparative data.